Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Immunodiagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], By Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), By End User (Hospitals, Clinics, Diagnostic Laboratories, Academic and Research Institutes, and Others), and Geography
- Report Code : TIPRE00003722
- Pages : 271
The immunodiagnostic market is expected to grow from US$ 17,948.62 million in 2021 to US$ 29,526.72 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2022 to 2028.
The increasing prevalence of infectious diseases and the growing use of point-of-care immunodiagnostics are the factors fueling the global immunodiagnostic market growth. However, factors such as inadequate treatment reimbursement scenarios are restraining the market growth.
Immunodiagnostics is a diagnostic methodology that primarily uses antigen-antibody reaction as its primary means of detection. Antibodies, specific for the desired antigen, can be conjugated with a radiolabel, fluorescent label, or color-forming enzyme and are used as a probe to detect it. The speed, accuracy, and simplicity of such tests have led to the development of rapid techniques for the diagnosis of diseases, microbes
Point-of-care testing (POCT) has become critical to patient-centric healthcare due to the need for rapid diagnostic results to determine accurate and faster treatment. A shift from centralized point-of-care testing to decentralized testing for chronic and infectious patients has resulted in convenient patient access to these diagnostics. The current approach to diagnosis and monitoring chronic conditions or detecting pathogens such as bacteria and viruses rely on immunoassay testing.
Advanced point-of-care devices enable rapid screening of up to three components from a single sample. Also, the point-of-care diagnostics (POCD) inclined toward mobile healthcare (mH) smart devices could revolutionize personalized healthcare monitoring and management, paving the way for next-generation POCTs. The infectious disease management can be significantly improved by POCTs, especially in developing countries where access to timely medical care is challenging and healthcare infrastructure is outdated and sparse. Additionally, the technologically developed diagnostic kits leading to fewer manual errors propel the immunodiagnostics market.
Innovative immunodiagnostic products are being developed by several market players. For instance, Thermo Fisher Scientific has developed immunodiagnostic products such as enzyme-linked immunoassay (ELISA) reagents and buffers, antibodies and detection probes, linking mechanisms, blocking buffers and detergents, detection substrates, and capture surfaces, along with services such as bioconjugation and detection. Further, on September 1, 2020, Roche launched SARS-CoV-2 Rapid Antigen Test. The Test is used in POC settings for symptomatic and asymptomatic people to help healthcare professionals identify the infection within 15 minutes.
The COVID-19 pandemic boosted the use of immunodiagnostics. According to the American Society for Clinical Pathology, in March 2020, the Cepheid Xpert Xpress SARS-CoV-2 test became the first POC COVID-19 detection assay to receive Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA).
Moreover, in oncology, an immunodiagnostic test can confirm the presence of a solid tumor by detecting known tumor-associated antigens or antibodies. Thus, the rising use of immunodiagnostics in cancer treatment is driving the immunodiagnostics market.
Product-Based Insights
Based on product, the immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment held the largest market share of US$ 9,980.87 million in 2021.On the other hand, chemiluminescence immunoassays (CLIA) is expected to witness the highest growth during the forecast period.
Clinical Indication-Based Insights
Based on clinical indication, the immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. The infectious diseases segment accounted for the largest share of the market in 2021, and it is expected to register the highest CAGR of 8.0% during the forecast period.
End User-Based Insights
Based on end user, the immunodiagnostics market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospitals segment held the largest share of the market in 2021. However, the clinics segment accounts for a CAGR of 8.5% during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the immunodiagnostics market are the World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine, among others.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Immunodiagnostics Market – By Product
1.3.2 Global Immunodiagnostics Market – By Clinical Indication
1.3.3 Global Immunodiagnostics Market – By End User
1.3.4 Global Immunodiagnostics Market– By Geography
2. Global Immunodiagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Immunodiagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Experts Opinion
5. Immunodiagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market– Global Analysis
6.1 Global Immunodiagnostics Market Revenue Forecast and Analysis
6.2 Global Immunodiagnostics Market, By Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Global Immunodiagnostics Market – Market Potential Analysis, By Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
6.7.1 Abbott Laboratories
6.7.1.1 F. Hoffmann-La Roche Ltd
7. Immunodiagnostics Market Analysis – by Product
7.1 Overview
7.2 Immunodiagnostics Market, By Product, 2021 & 2028 (%)
7.3 Enzyme-linked immunosorbent assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked immunosorbent assays (ELISA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Chemiluminescence immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. Immunodiagnostics Market Analysis – Clinical Indication
8.1 Overview
8.2 Global Immunodiagnostics Market Share by Clinical Indication – 2021 & 2028 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 COVID-19
8.3.3.1 Overview
8.3.3.2 COVID-19: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Tuberculosis
8.3.4.1 Overview
8.3.4.2 Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Lyme
8.3.5.1 Overview
8.3.5.2 Lyme: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.6 Infection Management
8.3.6.1 Overview
8.3.6.2 Infection Management: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.7 Zika
8.3.7.1 Overview
8.3.7.2 Zika: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.8 Treponema
8.3.8.1 Overview
8.3.8.2 Treponema: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.9 TORCH
8.3.9.1 Overview
8.3.9.2 TORCH: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.10 Measles and Mumps
8.3.10.1 Overview
8.3.10.2 Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.11 VZV
8.3.11.1 Overview
8.3.11.2 VZV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.12 EBV
8.3.12.1 Overview
8.3.12.2 EBV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Metabolics
8.6.1 Overview
8.6.2 Metabolics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. Immunodiagnostics Market Analysis – End User
9.1 Overview
9.2 Global Immunodiagnostics Market Share by End User – 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. Global Immunodiagnostics Market Revenue and Forecast to 2028– by Geography
10.1 North America: Immunodiagnostics Market
10.1.1 Overview
10.1.2 North America: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 North America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.1.4 North America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 North America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.1.5 North America Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6 North America: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2.1 US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3.1 US Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3.2 US Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2.1 Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3.1 Canada Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3.2 Canada Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2.1 Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3.1 Mexico Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3.2 Mexico Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2 Europe: Immunodiagnostics Market
10.2.1 Overview
10.2.2 Europe: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.2.3.1 Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.2.4 Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.2.4.1 Europe Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.2.4.2 Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.2.5 Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.6 Europe: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.1 Germany: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.2 Germany Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.2.1 Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.2.6.1.3 Germany Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.3.1 Germany Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.3.2 Germany Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.4 Germany: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.6.2 France: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.1 France: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.2 France Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.2.1 France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.3 France Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.3.1 France Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.3.2 France Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.4 France Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.6.3 UK: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.1 UK: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.2 UK Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.2.1 UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.3 UK Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.3.1 UK Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.3.2 UK Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.4 UK Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.6.4 Italy: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.1 Italy: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.2 Italy Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.2.1 Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.3 Italy Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.3.1 Italy Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.3.2 Italy Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.4 Italy Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.6.5 Spain: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.1 Spain: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.2 Spain Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.2.1 Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.3 Spain Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.3.1 Spain Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.3.2 Spain Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.4 Spain Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.6.6 Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.1 Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.2 Rest of Europe Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.2.1 Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.3 Rest of Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.3.1 Rest of Europe Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.3.2 Rest of Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.4 Rest of Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3 Asia Pacific: Immunodiagnostics Market
10.3.1 Overview
10.3.2 Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.3.3.1 Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.3.4 Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.3.4.1 Asia Pacific Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.3.4.2 Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.3.5 Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6 Asia Pacific: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2.1 China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3 China Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3.1 China Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3.2 China Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.4 China: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.2 Japan: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2.1 Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3 Japan Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3.1 Japan Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3.2 Japan Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.4 Japan Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.3 India: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 India: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2.1 India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3 India Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3.1 India Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3.2 India Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.4 India Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.4 Australia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 Australia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 Australia Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2.1 Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.3 Australia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.3.1 Australia Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.3.2 Australia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.4 Australia Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.5 South Korea: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 South Korea: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 South Korea Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2.1 South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.3 South Korea Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.3.1 South Korea Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.3.2 South Korea Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.4 South Korea Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2.1 Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3.1 Rest of Asia Pacific Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3.2 Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4 South & Central America: Immunodiagnostics Market
10.4.1 Overview
10.4.2 South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.3 South & Central America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.4.3.1 South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.4.4 South & Central America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.4.4.1 South & Central America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.4.4.2 South & Central America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.4.5 South & Central America Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6 South & Central America: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
10.4.6.1 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.2 Brazil Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.2.1 Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3 Brazil Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3.1 Brazil Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3.2 Brazil Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.4 Brazil: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.2 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.2 Argentina Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.2.1 Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3 Argentina Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3.1 Argentina Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3.2 Argentina Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.4 Argentina Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.3 Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.1 Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2 Rest of South & Central America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2.1 Rest of South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3 Rest of South & Central America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3.1 Rest of South & Central America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3.2 Rest of South & Central America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.4 Rest of South & Central America Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.5 Middle East & Africa: Immunodiagnostics Market
10.5.1 Overview
10.5.2 Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.3 Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.5.3.1 Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.5.4 Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.5.4.1 Middle East & Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.5.4.2 Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.5.5 Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.5.6 Middle East & Africa: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
10.5.6.1 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2 Saudi Arabia Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2.1 Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.5.6.1.3 Saudi Arabia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.3.1 Saudi Arabia Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.3.2 Saudi Arabia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.4 Saudi Arabia: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.5.6.2 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2 South Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2.1 South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.3 South Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.3.1 South Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.3.2 South Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.4 South Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.5.6.3 UAE: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 UAE: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.2 UAE Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.2.1 UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.3 UAE Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.3.1 UAE Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.3.2 UAE Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.4 UAE Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.5.6.4 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.4.1 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.4.2 Rest of Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.5.6.4.2.1 Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.5.6.4.3 Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.5.6.4.3.1 Rest of Middle East & Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.5.6.4.3.2 Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.5.6.4.4 Rest of Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Laboratory Animal Diet Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12. Global Immunodiagnostics Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Immunodiagnostics Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 DiaSorin S.p.A.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Danaher Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 PerkinElmer Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Svar Life Science AB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Siemens Healthineers AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Infectious Diseases and Funding
Table 2. North America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 4. North America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 6. North America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 7. North America Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 8. US Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 9. US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 10. US Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. US Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 12. US Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 13. US Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 14. Canada Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 15. Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 16. Canada Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 17. Canada Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 18. Canada Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 19. Canada Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 21. Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 22. Mexico Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 23. Mexico Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 24. Mexico Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 25. Mexico Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 26. Europe Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 27. Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 28. Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 29. Europe Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 30. Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 31. Europe Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 32. Germany Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 33. Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 34. Germany Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 35. Germany Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 36. Germany Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 37. Germany Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 38. France Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 39. France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 40. France Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 41. France Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 42. France Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 43. France Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 44. UK Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 45. UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 46. UK Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 47. UK Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 48. UK Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 49. UK Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 50. Italy Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 51. Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 52. Italy Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 53. Italy Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 54. Italy Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 55. Italy Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 56. Spain Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 57. Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 58. Spain Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 59. Spain Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 60. Spain Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 61. Spain Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 62. Rest of Europe Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 63. Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 64. Rest of Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 65. Rest of Europe Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 66. Rest of Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 67. Rest of Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 68. Asia Pacific Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 69. Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 70. Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 71. Asia Pacific Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 72. Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 73. Asia Pacific Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 74. China Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 75. China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 76. China Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 77. China Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 78. China Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 79. China Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 80. Japan Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 81. Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 82. Japan Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 83. Japan Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 84. Japan Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 85. Japan Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 86. India Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 87. India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 88. India Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 89. India Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 90. India Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 91. India Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 92. Australia Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 93. Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 94. Australia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 95. Australia Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 96. Australia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 97. Australia Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 98. South Korea Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 99. South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 100. South Korea Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 101. South Korea Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 102. South Korea Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 103. South Korea Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 104. Rest of Asia Pacific Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of Asia Pacific Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 108. Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 109. Rest of Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 110. South & Central America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 111. South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 112. South & Central America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 113. South & Central America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 114. South & Central America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 115. South & Central America Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 116. Brazil Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 117. Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 118. Brazil Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 119. Brazil Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 120. Brazil Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 122. Argentina Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 123. Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 124. Argentina Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 125. Argentina Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 128. Rest of South & Central America Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 129. Rest of South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 130. Rest of South & Central America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South & Central America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South & Central America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South & Central America Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 134. Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 135. Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 136. Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 137. Middle East & Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 138. Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 139. Middle East & Africa Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 140. Saudi Arabia Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 141. Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 142. Saudi Arabia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 143. Saudi Arabia Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 144. Saudi Arabia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 145. Saudi Arabia Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 146. South Africa Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 147. South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 148. South Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 149. South Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 150. South Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 151. South Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 152. UAE Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 153. UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 154. UAE Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 155. UAE Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 156. UAE Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 157. UAE Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 158. Rest of Middle East & Africa Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 159. Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 160. Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 161. Rest of Middle East & Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 162. Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 163. Rest of Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 164. Recent Inorganic Growth Strategies in the Immunodiagnostics Market
Table 165. Recent Organic Growth Strategies in the Immunodiagnostics Market
Table 166. Glossary of Terms, Immunodiagnostics Market
LIST OF FIGURES
Figure 1. Immunodiagnostics Market Segmentation
Figure 2. Immunodiagnostics Market Segmentation, By Region
Figure 3. Global Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Held the Largest Share of the Product Segment in Immunodiagnostics Market
Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Immunodiagnostics Market, By Geography (US$ Mn)
Figure 7. Global Immunodiagnostics Market– Leading Country Markets (US$ Million)
Figure 8. Global Immunodiagnostics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia-Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Immunodiagnostics Market– Revenue Forecast and Analysis – 2020 – 2028
Figure 16. Global Immunodiagnostics Market – By Geography Forecast and Analysis – 2022 – 2028
Figure 17. Market Positioning of Key Players in Immunodiagnostics Market
Figure 18. Global Immunodiagnostics Market – Market Potential Analysis, By Region
Figure 19. Global Immunodiagnostics Market – Comparative Company Analysis
Figure 20. Global Immunodiagnostics Market – Growth Strategy Analysis
Figure 21. Immunodiagnostics Market, by Product, 2021 & 2028 (%)
Figure 22. Enzyme-linked immunosorbent assays (ELISA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Chemiluminescence immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Vitamin D Assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. HIV Detection: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. HIV Ag/Ab Combo assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Other Tests: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Global Immunodiagnostics Market Share by Clinical Indication – 2021 & 2028 (%)
Figure 31. Infectious Diseases: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. COVID-19: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Tuberculosis: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Lyme: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Infection Management: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Zika: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Treponema: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. TORCH: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Measles and Mumps: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. VZV: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 41. EBV: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 43. Gastrointestinal: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 44. Metabolics: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 45. Endocrinology: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46. Hypertension: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 47. Growth: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 48. Diabetes: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 49. Thyroid: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 50. Reproductive endocrinology: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 51. Global Immunodiagnostics Market Share by End User – 2021 & 2028 (%)
Figure 52. Hospitals: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 53. Clinics: Immunodiagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 54. Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 56. Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. North America: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 58. North America Immunodiagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 59. North America: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
Figure 60. US: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. Canada: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Mexico: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. Europe: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 64. Europe Immunodiagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 65. Europe: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
Figure 66. Germany: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. France: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. UK: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. Italy: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 70. Spain: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 71. Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 72. Asia Pacific: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 73. Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 74. Asia Pacific: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
Figure 75. China: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 76. Japan: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 77. India: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 78. Australia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 79. South Korea: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 80. Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 81. South & Central America: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 82. South & Central America Immunodiagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 83. South & Central America: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
Figure 84. Brazil: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 85. Argentina: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 86. Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 87. Middle East & Africa: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 88. Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 89. Middle East & Africa: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
Figure 90. Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 91. South Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 92. UAE: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 93. Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 94. Impact of COVID-19 Pandemic on North American Countries Markets
Figure 95. Impact of COVID-19 Pandemic on European Countries Markets
Figure 96. Impact of COVID-19 Pandemic on Asia Pacific Countries Markets
Figure 97. Impact of COVID-19 Pandemic on South & Central American Countries Markets
Figure 98. Impact of COVID-19 Pandemic on Middle East & African Countries Markets
Figure 99. Growth Strategies in the Immunodiagnostics Market
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the immunodiagnostics market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The List of Companies – Immunodiagnostics Market
1. Abbott Laboratories
2. F. Hoffmann-La Roche Ltd
3. DiaSorin SpA
4. Danaher Corp
5. Thermo Fisher Scientific Inc
6. PerkinElmer Inc
7. Shenzhen Mindray Bio-Medical Electronics Co Ltd
8. bioMerieux SA
9. Svar Life Science AB
10. Siemens Healthineers AG
Growing Use of Point-of-Care Immunodiagnostics to Drive Immunodiagnostics Market
According to our new market research study on “Immunodiagnostics Market to 2028 – Global Analysis and Forecast – by Product, Clinical Indication, and End User,” the market is expected to grow from US$ 17,948.62 million in 2021 to US$ 29,526.72 million by 2028; it is expected to grow at a CAGR of 7.4% from 2022 to 2028. The report highlights trends prevailing in the market, and drivers and restraints pertaining to the global immunodiagnostics market growth.
The current trend in immunodiagnostics is microfluidics and magnetic beads with potential commercialization. These sensitive, specific, and time-saving methodologies are essential in understanding and diagnosing health conditions, including infectious diseases, metabolic disorders, and cardiac problems.
The increasing applications of immunodiagnostic solutions encouraged the development of targeted treatments and therapies for precision health. The prominent market players are also propelling the use of assay technology and adopting microfluidics and magnetic beads. For immunoassays, magnetic particles, such as Sera-Mag beads, offer a convenient alternative to plate-based ELISAs, as both rely on the same assay principle. Merck KGaA launched the Magna Chip Protein A magnetic beads. This recombinant Protein A is covalently bound to magnetic beads for chromatin immunoprecipitations (Chip assays) and provides users with a rapid, reproducible, and efficient reagent for collecting immunocomplexes than agarose beads.
In microfluidics, some immunodiagnostics target single biomarkers. However, a recent trend shows the detection of multiple analytes according to the complexity and the need to make early reliable diagnoses. For example, in 2019, OPKO Health Inc. gained approval from the US Food and Drug Administration (FDA) for prostate-specific antigen (PSA) testing that improves the accuracy of prostate cancer diagnosis and reduces unnecessary prostate biopsies. OPKO Health’s test uses microfluidics, a recent development in immunodiagnostics, to assay an array of biomarkers. On September 15, 2022, Siemens Healthineers released its new CE-marked SARS-CoV-2/FluA/FluB/HRSV assay, a PCR test, and the CLINITEST Rapid COVID-19 + Influenza Antigen Test. The new FTD SARS-CoV-2/FluA/FluB/HRSV assay enables comprehensive and semi-automated molecular testing for seasonal respiratory pathogens. The combination PCR test detects and differentiates clinically relevant viruses such as SARS-CoV-2, Influenza A, Influenza B, and HRSV A/B.
North America holds the largest share of the immunodiagnostics market; however, Asia Pacific is expected to register the highest CAGR during the forecast period. The North America immunodiagnostics market growth is attributed to factors such as the growing prevalence of various diseases, government support for advanced diagnostics adoption, and increasing efforts in R&D and other activities undertaken by market players. In addition, technological advancements in the diagnosis industry are likely to be a major market driver in the coming years.
The immunodiagnostics market in the US is expected to grow from US$ 7,754.51 million in 2021 to US$ 12,554.05 million by 2028; it is expected to grow at a CAGR of 7.2% from 2022 to 2028. The US is also experiencing growing prevalence and incidences of chronic conditions such as cancer and infectious diseases. Further, the US government is taking various measures to control the rising prevalence of chronic disorders. The country is spending heavily on healthcare expenditure that enables researchers to introduce various innovative procedures for the treatment of several chronic conditions. Hence, owing to the above-mentioned factors, the US contributed to the largest share of the market during the forecast period.
Abbott Laboratories; F. Hoffmann-La Roche Ltd; DiaSorin S.p.A.; Danaher Corp; Thermo Fisher Scientific Inc; PerkinElmer Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; bioMerieux SA; Svar Life Science AB; and Siemens Healthineers AG are the leading companies operating in the global immunodiagnostics market.
Global Immunodiagnostics Market, by Region, 2021 (%)
Source: The Insight Partners Analysis
By geography, the immunodiagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Related Reports
- $3,000.00 – $5,000.00
